702

WEIGHT LOSS OUTCOMES WITH SEMAGLUTIDE BASED ON DIABETES STATUS AND SEVERITY USING THE INDIVIDUALIZED METABOLIC SURGERY SCORE

Date
May 8, 2023
Explore related products in the following collection:

Loading...

Tracks

Related Products

Thumbnail for Q&A PANEL DISCUSSION
Q&A PANEL DISCUSSION
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease…
Thumbnail for MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
MACHINE-LEARNING DRIVEN, FULL PHENOTYPE MODEL AND SURROGATE POLYGENIC RISK SCORE MODEL FOR APPETITE PREDICT RESPONSE TO GLP-1 RECEPTOR AGONIST IN PATIENTS WITH OBESITY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Thumbnail for PHENOTYPES-TAILORED DIET ON WEIGHT LOSS
PHENOTYPES-TAILORED DIET ON WEIGHT LOSS
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease…
Thumbnail for REAL-WORLD TYPE 2 DIABETES MELLITUS REMISSION AFTER 14 YEARS OF BARIATRIC SURGERIES IN PATIENTS WITH BMI≥ 50 KG/M<sup>2</sup>: A MULTI-CENTERED STUDY
REAL-WORLD TYPE 2 DIABETES MELLITUS REMISSION AFTER 14 YEARS OF BARIATRIC SURGERIES IN PATIENTS WITH BMI≥ 50 KG/M<sup>2</sup>: A MULTI-CENTERED STUDY
BACKGROUND: Gastroesophageal reflux disease (GERD), with or without hiatal hernia (HH), affects millions of individuals worldwide, with a significant economic impact and loss of health-related quality of life…